Celsion Corporation Revenue and Competitors

Trenton, NJ USA

Location

$78.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Celsion Corporation's estimated annual revenue is currently $3.5M per year.(i)
  • Celsion Corporation's estimated revenue per employee is $129,630
  • Celsion Corporation's total funding is $78.8M.

Employee Data

  • Celsion Corporation has 27 Employees.(i)
  • Celsion Corporation grew their employee count by 0% last year.

Celsion Corporation's People

NameTitleEmail/Phone
1
Chief Accounting OfficerReveal Email/Phone
2
VP Preclinical ResearchReveal Email/Phone
3
Controller and Chief Accounting OfficerReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
SVP, Chief Financial Officer and Corporate SecretaryReveal Email/Phone
6
EVP and Chief Science OfficerReveal Email/Phone
7
EVP & Chief Science OfficerReveal Email/Phone
8
Sr. Manager, Quality AssuranceReveal Email/Phone
9
Sr. Executive AssistantReveal Email/Phone
10
Sr. Executive AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.5M55-21%N/AN/A
#2
$0.2M10%N/AN/A
#3
$8.5M55-29%N/AN/A
#4
$108.5M5002%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M68-23%$206.4MN/A
#8
$492.2M1503-15%$568MN/A
#9
$1.1M7-42%N/AN/A
#10
$4.5M290%N/AN/A
Add Company

What Is Celsion Corporation?

Celsion Corporation, based in Columbia, Maryland, is a research and development company dedicated to commercializing medical treatment systems for cancer and other diseases using focused heat technology delivered by patented microwave technology. Celsion has research, license or commercialization agreements with leading institutions such as Duke University Medical Center,Massachusetts Institute of Technology, Harbor UCLA Medical Center, the Center for Breast Surgery at Columbia Hospital in Florida, Montefiore Medical Center,Memorial Sloan Kettering Cancer Center in New York, Roswell Park Cancer Institute in Buffalo, New York, and Duke University.

keywords:N/A

$78.8M

Total Funding

27

Number of Employees

$3.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Celsion Corporation News

2022-04-17 - Celsion Corporation Highlighted its PLACCINE Vaccine ...

LAWRENCEVILLE, N.J., April 21, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based...

2022-03-30 - Celsion Corporation Reported Cash Position of $56.9 million ...

LAWRENCEVILLE, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based...

2022-03-30 - Celsion Corporation Reports 2021 Financial Results and ...

LAWRENCEVILLE, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage drug-development company...

2021-05-11 - CELSION CORPORATION Celsion : Receives $1.85 Million from the Sale of its New Jersey State Net Operating Losses

Non-Dilutive Funding Strengthens Balance Sheet, Extends Cash Runway Beyond 2024 Sale of an Additional $5.0 Million of State NOLs Expected in Future Years LAWRENCEVILLE, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immu ...

2021-04-06 - CELSION CORPORATION CELSION CORPORATION ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING

Lawrenceville, NJ, April 05, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of its previously announced registered direct offering of 11,538,462 shares of common stock at a purchase price of $1.30 per share, resulting in net ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.3M274%N/A
#2
N/A270%N/A
#3
$3.7M290%N/A
#4
$5.9M29-28%N/A
#5
$3.5M290%N/A